Alma Fulurija

A staged clinical development and evidence-generation framework for Group A Streptococcus vaccines

Group A Streptococcus (Strep A) causes substantial global morbidity and mortality, yet vaccine development faces scientific, regulatory, and strategic challenges. We propose a platform-agnostic, staged clinical development and evidence-generation framework aligning trial feasibil...